Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Angiogenesis inhibitor. Additionally we are shipping Vasohibin 2 Antibodies (22) and many more products for this protein.
Showing 2 out of 2 products:
to the best of our knowledge, these results are the first clinical data indicating that nuclear VASH2, but not cytoplasmic VASH2, promotes cell proliferation by driving the cell cycle from the G0/G1 to S phase.
MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
Suggest that overexpression of VASH2 in pancreatic ductal adenocarcinoma accelerated the pace of tumor development toward a more serious malignant phenotype and was associated with a poor clinical outcome.
VASH1 (show VASH1 Proteins) and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization.
VASH2 overexpression downregulated wild-type p53 (show TP53 Proteins).
VASH2 expressed in serous ovarian carcinoma cells promoted tumor growth and peritoneal dissemination by promoting angiogenesis.
This is the first study to report differences in the intracellular localization of the VASH2 protein and, hence, a new research direction on the study of VASH2
vasohibin-1 (show VASH1 Proteins) and vasohibin-2 mRNA are expressed in gastric cancer cells and in tumor-associated macrophages (TAMs), and their expressions are altered by hypoxia.
VASH2 contributes to the angiogenesis in hepatocellular carcinoma via an Small vasohibin binding protein-mediated paracrine mechanism.
Data suggest that VASH1 (show VASH1 Proteins) is expressed in vascular endothelium to terminate angiogenesis; VASH2 appears to be expressed in other cells (primarily mononuclear leukocytes) to promote angiogenesis. [REVIEW]
VASH2 may modulate the onset of tumors in the gastrointestinal tract by regulating tumor angiogenesis.
Loss of vasohibin-2 is associated with deficient angiogenesis in the termination sprouting front of endothelial cells.
Angiogenesis inhibitor. Inhibits network formation by endothelial cells.
, vasohibin-like protein